FDA Issues New Dietary Ingredient Safety Guidance
The agency released updated requirements for manufacturers to demonstrate the identity and safety of new dietary ingredients.
Updated on Oct. 20, 2026 in Nutrition
Live Poll
Should federal regulators impose stricter safety documentation requirements on new dietary supplement ingredients?
The FDA has finalized new guidance titled New Dietary Ingredient (NDI) Notifications and Related Issues to help firms prove the safety of ingredients. Manufacturers are now required to provide detailed information on product composition, manufacturing processes, and chemical characteristics.
Why it matters
This guidance is intended to help firms demonstrate that a new dietary ingredient can reasonably be expected to be safe under its intended conditions of use. It clarifies what evidence is required to meet federal safety standards for supplements reaching the market.
Manufacturers must file an NDI notification with the FDA 75 days before marketing an ingredient. The agency now recommends a 25-year history of widespread use as sufficient evidence for establishing ingredient safety.
The players
Food and Drug Administration
The Food and Drug Administration is the federal agency responsible for protecting public health by ensuring the safety and efficacy of human drugs, biological products, and the nation's food supply.
The details
Under the new framework, companies must submit comprehensive data on sourcing, cultivation, and analytical methods. The guidance also shifts from previous draft requirements by removing specific long-term animal and reproductive toxicity studies, while permitting alternative testing methods like in vitro and computational approaches.
Timeline
October 15, 1994: Threshold date for ingredients requiring NDI notification.
2011: Initial NDI draft guidance issued.
2024: FDA finalized section V on notification procedures.
October 19, 2026: FDA released final guidance on identity and safety.
Health Landscape
This guidance provides the regulatory framework for compliance with the Dietary Supplement Health and Education Act of 1994. By codifying modern testing methods, it marks a significant evolution in how the FDA oversees the safety profile of ingredients in the supplement market.
The new guidance standardizes the evidence requirements for manufacturers, which may lead to more consistent safety documentation for products found in your supplement cabinet. Consumers can expect manufacturers to provide clearer scientific backing for the ingredients used in their health and wellness routines.
The takeaway
The FDA is modernizing its safety evaluation process by accepting computational and in vitro data alongside traditional history of use. Manufacturers should prepare to meet these updated evidentiary standards before introducing new ingredients to the market.
What happens next
The FDA expects to make progress on additional NDI guidance sections in the coming months and plans to issue a distinct draft guidance addressing the interpretation of dietary substances.
Further reading
For more information on current federal regulations, visit the United States Nutrition section.
Live Poll
Should federal regulators impose stricter safety documentation requirements on new dietary supplement ingredients?
